Search research articles
Contact Us
Filters
Showing results (291-300 of 301) with videos related to
Page
of 31
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
August 1, 1998
Human melanoma-reactive CD4+ and CD8+ CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for tumor killing
L Rivoltini, M Radrizzani, P Accornero, et al.
The Journal of Experimental Medicine
|
January 1, 1995
Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8+ cytotoxic T lymphocytes
C Castelli, W J Storkus, M J Maeurer, et al.
Gene Therapy
|
February 16, 2000
Type I consensus interferon (CIFN) gene transfer into human melanoma cells up-regulates p53 and enhances cisplatin-induced apoptosis: implications for new therapeutic strategies with IFN-alpha
M Mecchia, P Matarrese, W Malorni, et al.
Critical Reviews in Immunology
|
January 7, 1998
Recognition of melanoma-derived antigens by CTL: possible mechanisms involved in down-regulating anti-tumor T-cell reactivity
L Rivoltini, D J Loftus, P Squarcina, et al.
Cancer Gene Therapy
|
January 23, 1999
Gene transfer into human dendritic antigen-presenting cells by vaccinia virus and adenovirus vectors
M Di Nicola, S Siena, M Bregni, et al.
British Journal of Cancer
|
September 15, 2001
CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation
G Della Torre, B Pasini, S Frigerio, et al.
Cancer Immunology, Immunotherapy : CII
|
June 1, 1997
Active immunization of metastatic melanoma patients with interleukin-2-transduced allogeneic melanoma cells: evaluation of efficacy and tolerability
F Belli, F Arienti, J Sulé-Suso, et al.
Human Gene Therapy
|
December 28, 1999
Vaccination of melanoma patients with interleukin 4 gene-transduced allogeneic melanoma cells
F Arienti, F Belli, F Napolitano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 27, 2013
Efficacy and safety of ipilimumab in patients with pre-treated, uveal melanoma
M Maio, R Danielli, V Chiarion-Sileni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 25, 2014
Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II study
A M Di Giacomo, P A Ascierto, P Queirolo, et al.
Page
of 31
Search research articles
Search
Showing results (291-300 of 301) with videos related to
Sort By:
Page
of 31
Journal of Immunology (Baltimore, Md. : 1950)
|
August 1, 1998
Human melanoma-reactive CD4+ and CD8+ CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for tumor killing
L Rivoltini, M Radrizzani, P Accornero, et al.
The Journal of Experimental Medicine
|
January 1, 1995
Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8+ cytotoxic T lymphocytes
C Castelli, W J Storkus, M J Maeurer, et al.
Gene Therapy
|
February 16, 2000
Type I consensus interferon (CIFN) gene transfer into human melanoma cells up-regulates p53 and enhances cisplatin-induced apoptosis: implications for new therapeutic strategies with IFN-alpha
M Mecchia, P Matarrese, W Malorni, et al.
Critical Reviews in Immunology
|
January 7, 1998
Recognition of melanoma-derived antigens by CTL: possible mechanisms involved in down-regulating anti-tumor T-cell reactivity
L Rivoltini, D J Loftus, P Squarcina, et al.
Cancer Gene Therapy
|
January 23, 1999
Gene transfer into human dendritic antigen-presenting cells by vaccinia virus and adenovirus vectors
M Di Nicola, S Siena, M Bregni, et al.
British Journal of Cancer
|
September 15, 2001
CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation
G Della Torre, B Pasini, S Frigerio, et al.
Cancer Immunology, Immunotherapy : CII
|
June 1, 1997
Active immunization of metastatic melanoma patients with interleukin-2-transduced allogeneic melanoma cells: evaluation of efficacy and tolerability
F Belli, F Arienti, J Sulé-Suso, et al.
Human Gene Therapy
|
December 28, 1999
Vaccination of melanoma patients with interleukin 4 gene-transduced allogeneic melanoma cells
F Arienti, F Belli, F Napolitano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 27, 2013
Efficacy and safety of ipilimumab in patients with pre-treated, uveal melanoma
M Maio, R Danielli, V Chiarion-Sileni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 25, 2014
Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II study
A M Di Giacomo, P A Ascierto, P Queirolo, et al.
Page
of 31